Simulations Plus Receivables 2010-2025 | SLP
Simulations Plus receivables from 2010 to 2025. Receivables can be defined as the total amount of collectibles for a company
Simulations Plus Annual Receivables
(Millions of US $) |
| 2024 |
$9 |
| 2023 |
$10 |
| 2022 |
$14 |
| 2021 |
$10 |
| 2020 |
$11 |
| 2019 |
$8 |
| 2018 |
$8 |
| 2017 |
$6 |
| 2016 |
$4 |
| 2015 |
$2 |
| 2014 |
$2 |
| 2013 |
$2 |
| 2012 |
$1 |
| 2011 |
$2 |
| 2010 |
$1 |
| 2009 |
$2 |
Simulations Plus Quarterly Receivables
(Millions of US $) |
| 2025-02-28 |
$16 |
| 2024-11-30 |
$13 |
| 2024-08-31 |
$9 |
| 2024-05-31 |
$10 |
| 2024-02-29 |
$13 |
| 2023-11-30 |
$10 |
| 2023-08-31 |
$10 |
| 2023-05-31 |
$10 |
| 2023-02-28 |
$11 |
| 2022-11-30 |
$12 |
| 2022-08-31 |
$14 |
| 2022-05-31 |
$19 |
| 2022-02-28 |
$15 |
| 2021-11-30 |
$13 |
| 2021-08-31 |
$10 |
| 2021-05-31 |
$17 |
| 2021-02-28 |
$15 |
| 2020-11-30 |
$10 |
| 2020-08-31 |
$11 |
| 2020-05-31 |
$14 |
| 2020-02-29 |
$11 |
| 2019-11-30 |
$10 |
| 2019-08-31 |
$8 |
| 2019-05-31 |
$10 |
| 2019-02-28 |
$8 |
| 2018-11-30 |
$8 |
| 2018-08-31 |
$8 |
| 2018-05-31 |
$10 |
| 2018-02-28 |
$8 |
| 2017-11-30 |
$7 |
| 2017-08-31 |
$6 |
| 2017-05-31 |
$6 |
| 2017-02-28 |
$6 |
| 2016-11-30 |
$4 |
| 2016-08-31 |
$4 |
| 2016-05-31 |
$6 |
| 2016-02-29 |
$5 |
| 2015-11-30 |
$5 |
| 2015-08-31 |
$2 |
| 2015-05-31 |
$5 |
| 2015-02-28 |
$4 |
| 2014-11-30 |
$4 |
| 2014-08-31 |
$2 |
| 2014-05-31 |
$3 |
| 2014-02-28 |
$3 |
| 2013-11-30 |
$2 |
| 2013-08-31 |
$2 |
| 2013-05-31 |
$3 |
| 2013-02-28 |
$3 |
| 2012-11-30 |
$2 |
| 2012-08-31 |
$1 |
| 2012-05-31 |
$3 |
| 2012-02-29 |
$3 |
| 2011-11-30 |
$2 |
| 2011-08-31 |
$2 |
| 2011-05-31 |
$3 |
| 2011-02-28 |
$2 |
| 2010-11-30 |
$2 |
| 2010-08-31 |
$1 |
| 2010-05-31 |
$2 |
| 2010-02-28 |
$2 |
| 2009-11-30 |
$2 |
| 2009-08-31 |
$2 |
| 2009-05-31 |
$3 |
| 2009-02-28 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.676B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
